These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 8200123

  • 1. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.
    Ballinger A.
    Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY.
    Am J Med; 2001 Jan 08; 110(1A):58S-61S. PubMed ID: 11166000
    [Abstract] [Full Text] [Related]

  • 3. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar 08; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 4. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ, Agrawal NM.
    Dig Dis; 1995 Jan 08; 13 Suppl 1():48-61. PubMed ID: 7697902
    [Abstract] [Full Text] [Related]

  • 5. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
    Graham DY.
    Helicobacter; 2002 Feb 08; 7(1):1-8. PubMed ID: 11886469
    [Abstract] [Full Text] [Related]

  • 6. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects.
    Lazzaroni M, Bianchi Porro G.
    Dig Liver Dis; 2001 Dec 08; 33 Suppl 2():S44-58. PubMed ID: 11827362
    [Abstract] [Full Text] [Related]

  • 7. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM, Dajani EZ.
    J Assoc Acad Minor Phys; 1992 Dec 08; 3(4):142-8. PubMed ID: 1392409
    [Abstract] [Full Text] [Related]

  • 8. [Curative and preventive treatment of NSAID-associated gastroduodenal ulcers].
    Dupas JL, Grigy C.
    Gastroenterol Clin Biol; 2004 Apr 08; 28 Spec No 3():C77-83. PubMed ID: 15366678
    [Abstract] [Full Text] [Related]

  • 9. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
    Hawkey CJ.
    Scand J Gastroenterol Suppl; 1996 Apr 08; 220():124-7. PubMed ID: 8898449
    [Abstract] [Full Text] [Related]

  • 10. Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis.
    Henriksson K, Uribe A, Sandstedt B, Nord CE.
    Dig Dis Sci; 1993 Sep 08; 38(9):1688-96. PubMed ID: 8359082
    [Abstract] [Full Text] [Related]

  • 11. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds.
    Pipkin G, Mills JG.
    Dig Dis; 1995 Jan 08; 13 Suppl 1():75-88. PubMed ID: 7697904
    [Abstract] [Full Text] [Related]

  • 12. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R, Armstrong D.
    Can J Gastroenterol; 1999 Mar 08; 13(2):135-42. PubMed ID: 10203432
    [Abstract] [Full Text] [Related]

  • 13. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers.
    Scheiman J, Isenberg J.
    Am J Med; 1998 Nov 02; 105(5A):32S-38S. PubMed ID: 9855174
    [Abstract] [Full Text] [Related]

  • 14. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G, Hopkins A, Akbar FA.
    Postgrad Med J; 1988 Nov 02; 64 Suppl 1():60-77. PubMed ID: 3138682
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R, Caselli M, Castellino G, Bajocchi G, Trotta F.
    Drug Saf; 1999 Jun 02; 20(6):527-43. PubMed ID: 10392669
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
    Fujikawa Y, Watanabe T, Tominaga K, Fujiwara Y, Sato H, Arakawa T.
    Nihon Rinsho; 2011 Jun 02; 69(6):1039-43. PubMed ID: 21688624
    [Abstract] [Full Text] [Related]

  • 17. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND.
    Am J Med; 1998 Mar 30; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [Abstract] [Full Text] [Related]

  • 18. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE.
    Postgrad Med J; 1988 Mar 30; 64 Suppl 1():7-11. PubMed ID: 3138683
    [Abstract] [Full Text] [Related]

  • 19. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK.
    J Fam Pract; 1994 Jan 30; 38(1):60-7. PubMed ID: 8289053
    [Abstract] [Full Text] [Related]

  • 20. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
    McCarthy DM.
    J Clin Gastroenterol; 1990 Jan 30; 12 Suppl 2():S13-20. PubMed ID: 1978842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.